questionText: To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Duchenne UK and (b) other patient advocacy groups on steps to increase access to the givinostat early access programme.
answerText: The Department has not had any discussions with ITF Pharma UK about the resources or guidance available to National Health Service trusts participating in the early access programme (EAP) for givinostat.Department officials have had discussions with colle...
heading: Givinostat